ID: ALA3827338

Max Phase: Preclinical

Molecular Formula: C51H63BrClN13O11S

Molecular Weight: 1181.57

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COCCN(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(N)=O)C(=O)CN(NC(=O)N[C@H](C)c1ccccc1)C(=O)CN(NC(=O)c1ccc(Cl)cc1)C(=O)Cn1nc(-c2ccc(-c3ccc(Br)cc3)s2)oc1=O

Standard InChI:  InChI=1S/C51H63BrClN13O11S/c1-34(35-10-4-3-5-11-35)57-50(74)60-65(31-45(70)63(26-27-76-2)30-44(69)62(25-9-7-23-55)29-43(68)61(28-42(56)67)24-8-6-22-54)46(71)32-64(58-48(73)37-14-18-39(53)19-15-37)47(72)33-66-51(75)77-49(59-66)41-21-20-40(78-41)36-12-16-38(52)17-13-36/h3-5,10-21,34H,6-9,22-33,54-55H2,1-2H3,(H2,56,67)(H,58,73)(H2,57,60,74)/t34-/m1/s1

Standard InChI Key:  HVAHUZXIBUJYKW-UUWRZZSWSA-N

Associated Targets(Human)

Platelet-activating factor acetylhydrolase IB beta subunit 79 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1181.57Molecular Weight (Monoisotopic): 1179.3363AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Sarma BK, Liu X, Kodadek T..  (2016)  Identification of selective covalent inhibitors of platelet activating factor acetylhydrolase 1B2 from the screening of an oxadiazolone-capped peptoid-azapeptoid hybrid library.,  24  (17): [PMID:27160052] [10.1016/j.bmc.2016.04.047]

Source